These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


449 related items for PubMed ID: 15498564

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atarés B, Llorens V, Gomez Tortosa E, del Ser T, Muñoz DG, de Yebenes JG.
    Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
    [Abstract] [Full Text] [Related]

  • 3. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE.
    J Mol Biol; 2002 Jan 25; 315(4):799-807. PubMed ID: 11812148
    [Abstract] [Full Text] [Related]

  • 4. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
    Conway KA, Harper JD, Lansbury PT.
    Nat Med; 1998 Nov 25; 4(11):1318-20. PubMed ID: 9809558
    [Abstract] [Full Text] [Related]

  • 5. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y, Kawamoto Y, Tomimoto H, Takahashi R, Ihara M.
    Acta Neuropathol; 2006 Dec 25; 112(6):681-9. PubMed ID: 16957925
    [Abstract] [Full Text] [Related]

  • 6. Ubiquitination of alpha-synuclein.
    Nonaka T, Iwatsubo T, Hasegawa M.
    Biochemistry; 2005 Jan 11; 44(1):361-8. PubMed ID: 15628878
    [Abstract] [Full Text] [Related]

  • 7. Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation.
    Kotzbauer PT, Giasson BI, Kravitz AV, Golbe LI, Mark MH, Trojanowski JQ, Lee VM.
    Exp Neurol; 2004 Jun 11; 187(2):279-88. PubMed ID: 15144854
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE, Wersinger C, Tomita Y, Sidhu A.
    Biochemistry; 2004 May 11; 43(18):5539-50. PubMed ID: 15122920
    [Abstract] [Full Text] [Related]

  • 12. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K, Cochran EJ, Murrell JR, Polymeropoulos MH, Shannon KM, Crowther RA, Goedert M, Ghetti B.
    Acta Neuropathol; 2005 Sep 11; 110(3):298-305. PubMed ID: 15981014
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE, Gispert-Sanchez S, Murphy D, Auburger G, Myers RR, Nussbaum RL.
    Neurobiol Aging; 2005 Jan 11; 26(1):25-35. PubMed ID: 15585343
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.